ROYAL BANK OF CANADA - ALLIQUA BIOMEDICAL INC ownership

ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621200. A total of 31 filers reported holding ALLIQUA BIOMEDICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALLIQUA BIOMEDICAL INC
ValueSharesWeighting
Q3 2017$2,0000.0%6,0000.0%0.00%
Q2 2017$2,000
-66.7%
6,000
-45.5%
0.00%
Q1 2017$6,000
-40.0%
11,013
-33.3%
0.00%
Q4 2016$10,000
-16.7%
16,500
+13.8%
0.00%
Q3 2016$12,000
-29.4%
14,500
-8.1%
0.00%
Q2 2016$17,000
+30.8%
15,771
+1.0%
0.00%
Q1 2016$13,000
-81.4%
15,617
-52.0%
0.00%
Q4 2015$70,000
-74.1%
32,517
-61.8%
0.00%
Q3 2015$270,000
-21.3%
85,017
+30.8%
0.00%
Q2 2015$343,00065,0000.00%
Other shareholders
ALLIQUA BIOMEDICAL INC shareholders Q2 2017
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 583,026$653,0000.28%
SUFFOLK CAPITAL MANAGEMENT LLC 1,206,127$1,351,0000.17%
SABBY MANAGEMENT, LLC 1,500,000$1,680,0000.09%
Tekla Capital Management LLC 1,650,000$1,848,0000.08%
J. Goldman & Co LP 540,000$605,0000.03%
Chicago Partners Investment Group LLC 6,453$7,0000.00%
Edge Wealth Management LLC 4,930$5,0000.00%
Acrospire Investment Management LLC 2,400$3,0000.00%
US BANCORP \DE\ 181,732$204,0000.00%
Renaissance Technologies 271,500$304,0000.00%
View complete list of ALLIQUA BIOMEDICAL INC shareholders